BOI:EPA
Boiron SA
€17.60
arrow_downward
-1.68%(-0.30) 1D
Oct 26, 5:35:07 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€18.10
High
€18.25
Low
€17.60
Mkt. cap
314.06M
Avg. vol.
6.75K
Volume
4.70K
P/E ratio
11.67
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€18.10
High
€18.25
Low
€17.60
Mkt. cap
314.06M
Avg. vol.
6.75K
Volume
4.70K
P/E ratio
11.67
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
TradingView
·
52 minutes ago
Dow, S&P 500, Nasdaq Futures Climb As Tech Stocks Get A Boost From Anthropic IPO: SOFI, BB, PYPL, CLS In Focus
Yahoo Finance
·
7 hours ago
The 2 S&P 500 Stocks That Could Possibly Hold Up the Whole Index if the AI Trade Collapses
MarketWatch
·
6 hours ago
Why Lumentum’s stock led the S&P 500 higher on Monday
ChartMill
·
7 hours ago
S&P 500 Top Movers: Gainers and Losers in Today's US Session
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA